162 related articles for article (PubMed ID: 9107599)
1. Influenza vaccination: cost-effective health care for the older adult?
Hampson AW; Irving LB
J Qual Clin Pract; 1997 Mar; 17(1):3-11. PubMed ID: 9107599
[TBL] [Abstract][Full Text] [Related]
2. Influenza vaccination health impact and cost effectiveness among adults aged 50 to 64 and 65 and older.
Maciosek MV; Solberg LI; Coffield AB; Edwards NM; Goodman MJ
Am J Prev Med; 2006 Jul; 31(1):72-9. PubMed ID: 16777545
[TBL] [Abstract][Full Text] [Related]
3. Could a federal program to promote influenza vaccination among elders be cost-effective?
Patel MS; Davis MM
Prev Med; 2006 Mar; 42(3):240-6. PubMed ID: 16480761
[TBL] [Abstract][Full Text] [Related]
4. [Cost-effectiveness analysis of antigrippal vaccination in a rural population (La Victoria, Cordoba)].
Gavira FJ; Lardinois R
Med Clin (Barc); 1990 May; 94(20):777-81. PubMed ID: 2118204
[TBL] [Abstract][Full Text] [Related]
5. The cost-effectiveness of a universal influenza vaccination program for adults aged 50-64 years in Australia.
Newall AT; Scuffham PA; Kelly H; Harsley S; Macintyre CR
Vaccine; 2008 Apr; 26(17):2142-53. PubMed ID: 18343537
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness of influenza vaccination of healthy children.
Salo H; Kilpi T; Sintonen H; Linna M; Peltola V; Heikkinen T
Vaccine; 2006 Jun; 24(23):4934-41. PubMed ID: 16678945
[TBL] [Abstract][Full Text] [Related]
7. Influenza vaccines provide diminished protection but are cost-saving in older adults.
Deans GD; Stiver HG; McElhaney JE
J Intern Med; 2010 Feb; 267(2):220-7. PubMed ID: 20175868
[TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness of live attenuated influenza vaccine versus inactivated influenza vaccine among children aged 24-59 months in the United States.
Luce BR; Nichol KL; Belshe RB; Frick KD; Li SX; Boscoe A; Rousculp MD; Mahadevia PJ
Vaccine; 2008 Jun; 26(23):2841-8. PubMed ID: 18462851
[TBL] [Abstract][Full Text] [Related]
9. [Cost-effectiveness of influenza vaccination The Netherlands].
Reinders A; Postma MJ; Govaert TM; Sprenger MJ
Ned Tijdschr Geneeskd; 1997 Jan; 141(2):93-7. PubMed ID: 9036354
[TBL] [Abstract][Full Text] [Related]
10. Establishing the health and economic impact of influenza vaccination within the European Union 25 countries.
Ryan J; Zoellner Y; Gradl B; Palache B; Medema J
Vaccine; 2006 Nov; 24(47-48):6812-22. PubMed ID: 17034909
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness of influenza vaccination in working-age cancer patients.
Avritscher EB; Cooksley CD; Geraci JM; Bekele BN; Cantor SB; Rolston KV; Elting LS
Cancer; 2007 Jun; 109(11):2357-64. PubMed ID: 17457827
[TBL] [Abstract][Full Text] [Related]
12. Influence of clinical case definitions with differing levels of sensitivity and specificity on estimates of the relative and absolute health benefits of influenza vaccination among healthy working adults and implications for economic analyses.
Nichol KL; Mendelman P
Virus Res; 2004 Jul; 103(1-2):3-8. PubMed ID: 15163481
[TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness analysis of influenza and pneumococcal vaccinations among elderly people in Japan.
Cai L; Uchiyama H; Yanagisawa S; Kamae I
Kobe J Med Sci; 2006; 52(3-4):97-109. PubMed ID: 16855372
[TBL] [Abstract][Full Text] [Related]
14. [Study on the effectiveness and cost-benefit of influenza vaccine on elderly population in Beijing city].
Liu M; Liu GF; Wang Y; Zhao W; Wang L; Shi W; Wen SY
Zhonghua Liu Xing Bing Xue Za Zhi; 2005 Jun; 26(6):412-6. PubMed ID: 16185449
[TBL] [Abstract][Full Text] [Related]
15. Utility of virosomal adjuvated influenza vaccines: a review of the literature.
Gasparini R; Lai P
J Prev Med Hyg; 2010 Mar; 51(1):1-6. PubMed ID: 20853669
[TBL] [Abstract][Full Text] [Related]
16. Vaccination versus treatment of influenza in working adults: a cost-effectiveness analysis.
Rothberg MB; Rose DN
Am J Med; 2005 Jan; 118(1):68-77. PubMed ID: 15639212
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness of universal influenza vaccination in a pregnant population.
Roberts S; Hollier LM; Sheffield J; Laibl V; Wendel GD
Obstet Gynecol; 2006 Jun; 107(6):1323-9. PubMed ID: 16738159
[TBL] [Abstract][Full Text] [Related]
18. Medical economics in the field of influenza--past, present and future.
Szucs TD
Virus Res; 2004 Jul; 103(1-2):25-30. PubMed ID: 15163484
[TBL] [Abstract][Full Text] [Related]
19. The cost effectiveness of influenza vaccination for adults aged 50 to 64 years: a model-based analysis for Spain.
Aballéa S; De Juanes JR; Barbieri M; Martin M; Chancellor J; Oyagüez I; Verwee B; Largeron N
Vaccine; 2007 Sep; 25(39-40):6900-10. PubMed ID: 17764790
[TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness and socio-economic aspects of childhood influenza vaccination.
Nichol KL
Vaccine; 2011 Oct; 29(43):7554-8. PubMed ID: 21820477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
